☰

Erin L. Winstanley, Ph.D. - Publications

Affiliations: 
2006 Johns Hopkins University, Baltimore, MD 
Area:
Public Health
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zheng W, Cavrak M, Bowles H, Deng Y, Wen S, Gao S, Lander L, Berry J, Winstanley EL. 10-year retention of a comprehensive treatment model of buprenorphine for opioid use disorder. Journal of Addictive Diseases. 1-8. PMID 38400724 DOI: 10.1080/10550887.2024.2315366  0.317
2024 Lundstrom EW, Dai Z, Groth CP, Hendricks B, Winstanley EL, Abate M, Smith GS. Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study. Substance Abuse Treatment, Prevention, and Policy. 19: 4. PMID 38178238 DOI: 10.1186/s13011-023-00587-2  0.33
2020 Mahoney JJ, Winstanley EL, Lander LR, Berry JH, Marshalek PJ, Haut MW, Marton JL, Kimble WD, Armistead M, Wen S, Cai Y, Hodder SL. High prevalence of co-occurring substance use in individuals with opioid use disorder. Addictive Behaviors. 114: 106752. PMID 33348147 DOI: 10.1016/j.addbeh.2020.106752  0.338
2020 Stover AN, Rockett IRH, Smith GS, LeMasters T, Scott VG, Kelly KM, Winstanley EL. Feasibility and acceptability of safety screening among patients receiving addiction treatment. Journal of Substance Abuse Treatment. 117: 108092. PMID 32811626 DOI: 10.1016/J.Jsat.2020.108092  0.433
2020 Hines KL, Garofoli GK, Garofoli MP, Elswick BM, Winstanley EL. Impact of naloxone education for patients receiving buprenorphine-containing prescriptions indicated for opioid use disorder at an independent community pharmacy. Journal of the American Pharmacists Association : Japha. PMID 32800678 DOI: 10.1016/J.Japh.2020.07.015  0.428
2020 Winstanley EL, Mahoney JJ, Lander LR, Berry JH, Marshalek P, Zheng W, Haut MW. Something to despair: Gender differences in adverse childhood experiences among rural patients. Journal of Substance Abuse Treatment. 116: 108056. PMID 32741501 DOI: 10.1016/J.Jsat.2020.108056  0.334
2020 Winstanley EL. The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic. The International Journal On Drug Policy. 102796. PMID 32499119 DOI: 10.1016/J.Drugpo.2020.102796  0.3
2020 Lander LR, Zheng W, Hustead JD, Mahoney JJ, Berry JH, Marshalek P, Winstanley EL. Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program. Journal of the Neurological Sciences. 411: 116712. PMID 32058182 DOI: 10.1016/J.Jns.2020.116712  0.42
2019 Winstanley EL, Stover AN, Feinberg J. Concurrent Alcohol and Opioid Use Among Harm Reduction Clients. Addictive Behaviors. 100: 106027. PMID 31683186 DOI: 10.1016/J.Addbeh.2019.06.016  0.402
2019 Winstanley EL, Stover AN. The impact of the opioid epidemic on children and adolescents. Clinical Therapeutics. PMID 31303278 DOI: 10.1016/J.Clinthera.2019.06.003  0.401
2019 Winstanley EL, Lander LR, Berry JH, Mahoney JJ, Zheng W, Herschler J, Marshalek P, Sayres S, Mason J, Haut MW. West Virginia's model of buprenorphine expansion: Preliminary results. Journal of Substance Abuse Treatment. PMID 31221524 DOI: 10.1016/J.Jsat.2019.05.005  0.396
2018 Penm J, MacKinnon NJ, Connelly C, Mashni R, Lyons MS, Hooker EA, Winstanley EL, Carlton-Ford S, Tolle E, Boone J, Koechlin K, Defiore-Hyrmer J. Emergency Physicians' Perception of Barriers and Facilitators for Adopting an Opioid Prescribing Guideline in Ohio: A Qualitative Interview Study. The Journal of Emergency Medicine. PMID 30342861 DOI: 10.1016/J.Jemermed.2018.09.005  0.406
2018 Penm J, MacKinnon NJ, Mashni R, Lyons MS, Hooker EA, Winstanley EL, Carlton-Ford S, Connelly C, Tolle E, Boone J, Koechlin K, Defiore-Hyrmer J. Statewide cross-sectional survey of emergency departments' adoption and implementation of the Ohio opioid prescribing guidelines and opioid prescribing practices. Bmj Open. 8: e020477. PMID 29961010 DOI: 10.1136/Bmjopen-2017-020477  0.396
2018 Winstanley EL, Zhang Y, Mashni R, Schnee S, Penm J, Boone J, McNamee C, MacKinnon NJ. Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing. Drug and Alcohol Dependence. 188: 169-174. PMID 29778769 DOI: 10.1016/J.Drugalcdep.2018.03.036  0.418
2017 Winstanley EL, Mashni R, Schnee S, Miller N, Mashni SM. The development and feasibility of a pharmacy-delivered opioid intervention in the emergency department. Journal of the American Pharmacists Association : Japha. 57: S87-S91. PMID 28292506 DOI: 10.1016/J.Japh.2017.01.021  0.365
2017 Penm J, MacKinnon NJ, Boone JM, Ciaccia A, McNamee C, Winstanley EL. Strategies and policies to address the opioid epidemic: A case study of Ohio. Journal of the American Pharmacists Association : Japha. PMID 28189539 DOI: 10.1016/J.Japh.2017.01.001  0.33
2016 Butler MM, Ancona RM, Beauchamp GA, Yamin CK, Winstanley EL, Hart KW, Ruffner AH, Ryan SW, Ryan RJ, Lindsell CJ, Lyons MS. Emergency Department Prescription Opioids as an Initial Exposure Preceding Addiction. Annals of Emergency Medicine. PMID 26875061 DOI: 10.1016/J.Annemergmed.2015.11.033  0.427
2016 Winstanley EL, Clark A, Feinberg J, Wilder CM. Barriers to implementation of opioid overdose prevention programs in Ohio. Substance Abuse. 37: 42-6. PMID 26682929 DOI: 10.1080/08897077.2015.1132294  0.403
2015 Wilder CM, Miller SC, Tiffany E, Winhusen T, Winstanley EL, Stein MD. Risk Factors for Opioid Overdose and Awareness of Overdose Risk Among Veterans Prescribed Chronic Opioids for Addiction or Pain. Journal of Addictive Diseases. 0. PMID 26566771 DOI: 10.1080/10550887.2016.1107264  0.378
2015 Clark A, Winstanley EL, Martsolf DS, Rosen M. Implementation of an inpatient opioid overdose prevention program. Addictive Behaviors. 53: 141-145. PMID 26517710 DOI: 10.1016/J.Addbeh.2015.10.006  0.399
2015 Winstanley EL, Clark A, Wilder CM. Response to "Quality Assessment Errors and Study Misclassification Threaten Systematic Review Validity: Community Opioid Overdose Prevention and Naloxone Distribution Programs Review". Journal of Addiction Medicine. 9: 503-4. PMID 26517326 DOI: 10.1097/Adm.0000000000000160  0.339
2015 Winstanley EL, Clark AK, Feinberg J. Implementation of nasal naloxone across health-care settings: a case report from Ohio Addiction Science & Clinical Practice. 10. DOI: 10.1186/1940-0640-10-S1-A72  0.414
2015 Winstanley EL, Clark A. Risk factors associated with overdose among patients seeking treatment for opioid dependence Drug and Alcohol Dependence. 146: e25. DOI: 10.1016/J.Drugalcdep.2014.09.748  0.391
2014 Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. American Journal of Public Health. 104: 2023-9. PMID 25211712 DOI: 10.2105/Ajph.2014.302147  0.44
2014 Wilder CM, Brason FW, Clark AK, Galanter M, Walley AY, Winstanley EL. Development and implementation of an opioid overdose prevention program within a preexisting substance use disorders treatment center. Journal of Addiction Medicine. 8: 164-9. PMID 24874760 DOI: 10.1097/Adm.0000000000000032  0.428
2014 Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of Addiction Medicine. 8: 153-63. PMID 24874759 DOI: 10.1097/Adm.0000000000000034  0.407
2014 Winstanley EL, Brigham GS, Babcock D, Winhusen T. Improving treatment for opioid dependence: a perspective from the Ohio Valley node of the NIDA Clinical Trials Network. Progress in Community Health Partnerships : Research, Education, and Action. 8: 99-107. PMID 24859107 DOI: 10.1353/Cpr.2014.0002  0.419
2014 Umbricht A, DeFulio A, Winstanley EL, Tompkins DA, Peirce J, Mintzer MZ, Strain EC, Bigelow GE. Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial. Drug and Alcohol Dependence. 140: 92-100. PMID 24814607 DOI: 10.1016/J.Drugalcdep.2014.03.033  0.313
2012 Winstanley EL, Steinwachs DM, Stitzer ML, Fishman MJ. Adolescent Substance Abuse and Mental Health: Problem Co-Occurrence and Access to Services. Journal of Child & Adolescent Substance Abuse. 21: 310-322. PMID 24532964 DOI: 10.1080/1067828X.2012.709453  0.534
2012 Winstanley EL, Gay J, Roberts L, Moseley J, Hall O, Beeghly BC, Winhusen T, Somoza E. Prescription drug abuse as a public health problem in Ohio: a case report. Public Health Nursing (Boston, Mass.). 29: 553-62. PMID 23078426 DOI: 10.1111/J.1525-1446.2012.01043.X  0.338
2010 Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Addiction (Abingdon, England). 105: 1669-76. PMID 20626723 DOI: 10.1111/J.1360-0443.2010.03015.X  0.381
2008 Winstanley EL, Steinwachs DM, Ensminger ME, Latkin CA, Stitzer ML, Olsen Y. The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug and Alcohol Dependence. 92: 173-82. PMID 17913396 DOI: 10.1016/J.Drugalcdep.2007.07.012  0.527
Show low-probability matches.